Nara-ken, Japan

Sachiko Sakakibara


Average Co-Inventor Count = 13.6

ph-index = 2

Forward Citations = 17(Granted Patents)


Location History:

  • Nara-ken, JP (2003 - 2008)
  • Aichi-ken, JP (2008)

Company Filing History:


Years Active: 2003-2008

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Sachiko Sakakibara: Innovator in Pharmaceutical Chemistry

Introduction

Sachiko Sakakibara is a prominent inventor based in Nara-ken, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with anti-inflammatory properties. With a total of 5 patents to her name, her work has had a notable impact on medical research and drug development.

Latest Patents

Sakakibara's latest patents include innovative pyridine derivatives and pyrimidine compounds. One of her notable inventions is a compound with the general formula that exhibits excellent anti-inflammatory activity and other biological effects. Another significant patent involves an optically active compound, specifically (−)-7-[2-(cyclopropylmethoxy)-6-hydroxyphenyl]-5-[(3S)-3-piperidinyl]-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one, which also demonstrates remarkable anti-inflammatory properties.

Career Highlights

Throughout her career, Sachiko Sakakibara has worked with leading companies in the pharmaceutical industry, including Bayer Aktiengesellschaft and Bayer Healthcare Aktiengesellschaft. Her expertise in medicinal chemistry has allowed her to contribute to various projects aimed at developing effective therapeutic agents.

Collaborations

Sakakibara has collaborated with notable colleagues such as Toshiki Murata and Hiroki Sato. These partnerships have facilitated the advancement of her research and the successful development of her patented compounds.

Conclusion

Sachiko Sakakibara's contributions to pharmaceutical chemistry and her innovative patents highlight her role as a leading inventor in her field. Her work continues to influence the development of new therapeutic agents that address critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…